通过抑制cGAS-STING通路的激活,GDF15减缓了帕金森病的进展
Jianli Wang1,2, Ting Geng3, Xiaomei Yao2
1Department of Neurology, Qilu Hospital of Shandong University, No.107 Wenhua West Road, Lixia District, Jinan, 250012, Shandong, China.
Molecular and cellular biochemistry
|April 3, 2025
概括
增长差异化因子15 (GDF15) 通过抑制铁和炎症来保护帕金森病 (PD) 中的多巴胺神经元损伤. GDF15抑制了cGAS-STING通路,为PD提供了一个潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 增长差异化因子15 (GDF15) 与先天免疫有关.
- 目前尚不清楚GDF15在帕金森病 (PD) 发病过程中的作用.
- 研究GDF15在PD中的功能可能会揭示新的治疗点.
研究的目的:
- 阐明GDF15在帕金森病中的作用和分子机制.
- 在PD模型中确定GDF15是否影响多巴胺神经元损伤,铁亡和炎症.
- 探索cGAS-STING通路对GDF15介导的PD影响的参与.
主要方法:
- 评估了GDF15蛋白和mRNA表达,使用免疫光学,西斑和qRT-PCR.
- 评估的铁灭标志物,包括铁含量和线粒体功能.
- 利用了PD的细胞和小鼠模型,包括MPP+诱导的SH-SY5Y细胞和PD小鼠,具有GDF15敲击和过度表达.
主要成果:
- 在PD模型 (PD小鼠和MPP+治疗的SH-SY5Y细胞) 中,GDF15的表达被上调.
- 在PD模型中,GDF15 knockdown 加剧了多巴胺神经元损伤,铁亡和炎症.
- GDF15敲击激活了cGAS-STING通路,而GDF15治疗逆转了这些影响.
结论:
- 通过减弱多巴胺神经元损伤,GDF15在帕金森病中起着保护作用.
- GDF15抑制了PD中的铁和炎症,部分是通过抑制cGAS-STING通路.
- GDF15代表了缓解PD进展的潜在治疗标.
相关概念视频
Parkinson's Disease: Treatment
162
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
162
Parkinson's Disease: Overview
353
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
353
GPCR Desensitization
5.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K
Activation and Inactivation of G Proteins
6.5K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.5K


